ATAI Life Sciences AG
- SEC CIK
- 0001776242
No open-market purchases or sales filed in the past year.
Current role at each company
- CMPS COMPASS Pathways plc10% Owneras of Sep 27, 2024
- IGXT IntelGenx Technologies Corp.10% Owneras of May 3, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists ATAI Life Sciences AG as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CMPS COMPASS Pathways plc
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 27, 2024 (view filing)8:00 PM ET | Sep 26 | 1 day | ATAI Life Sciences AG and 1 other10% Owner | SSale | −2.66M | $6.05 | −$16.1M | −27.8%6.91M after |
IGXT IntelGenx Technologies Corp.
10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 12, 2024 (view filing)9:36 PM ET | Nov 28, 2023 | 105 daysLate | ATAI Life Sciences AG and 1 other10% Owner | PPurchase | +8.11M | – | – | –16.1M after | Derivative2 lots |
| Sep 5, 2023 (view filing)9:00 PM ET | Aug 31 | 5 days | ATAI Life Sciences AG and 1 other10% Owner | PPurchase | +24.0M | – | – | –12.0M after | Derivative2 lots |